Inadvertent tarsorrhaphy secondary to Dermabond.
Rouvelas
H
H
Maimonides Medical Center, Brooklyn, New York, USA. helenmed@hotmail.com
Saffra
N
N
Rosen
M
M
D002675:Child, Preschool; D003487:Cyanoacrylates / Q000009:adverse effects*; D004638:Emergency Treatment / Q000009:adverse effects* / Q000379:methods*; D004643:Emollients / Q000627:therapeutic use; D005143:Eyelids / Q000293:injuries*; D005546:Forehead / Q000293:injuries; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D010577:Petrolatum / Q000627:therapeutic use; D014014:Tissue Adhesives / Q000009:adverse effects*; D014947:Wounds and Injuries / Q000188:drug therapy
D003487:Cyanoacrylates; D004643:Emollients; D014014:Tissue Adhesives; C119247:octylcyanoacrylate; D010577:Petrolatum